12:54 CET
E³ 119 - Early detection of ovarian cancer
Oncologic Imaging Genitourinary Evidence-Based Imaging
Wednesday, February 27, 08:30 - 10:00
Type of session: E³ - ECR Academies: Hot Topics in GU Cancer
Topic: Oncologic Imaging, Genitourinary, Evidence-Based Imaging
Moderator: R. Forstner (Salzburg/AT)

08:30
Chairperson's introduction
R. Forstner; Salzburg/AT
08:36
A. Current guidance on screening and familial ovarian cancer (part 1)
A. G. Rockall; London/GB
Learning Objectives

1. To be aware of the implications of results of recent screening trials.
2. To be aware of BRCA gene testing and treatment implications.
3. To know the guidance on screening high risk groups.

08:50
A. Current guidance on screening and familial ovarian cancer (part 2)
A. George; London/GB
Learning Objectives

1. To be aware of the implications of results of recent screening trials.
2. To be aware of BRCA gene testing and treatment implications.
3. To know the guidance on screening high risk groups.

09:04
B. ORADS: ultrasound and International Ovarian Tumor Analysis (IOTA) group models
R. F. Andreotti; Nashville/US
Learning Objectives

1. To understand a new lexicon for ovarian/adnexal mass evaluation on ultrasound.
2. To understand the use of the lexicon in the development of a risk stratification and management system.
3. To apply O-RADS-US to case management.

Abstract

“O-RADS” is an acronym for an Ovarian-Adnexal Imaging-Reporting-Data System which is being developed by an international committee that is sponsored by the American College of Radiology (ACR) and will function as a quality assurance tool for the standardised ultrasound (US) and magnetic resonance imaging (MRI) description of ovarian/adnexal pathology. The O-RADS Committee has published a lexicon for describing US imaging characteristics of ovarian/adnexal masses. The terminology has been applied to a risk stratification classification for consistent follow up and management in clinical practice. The use of these internationally agreed upon standardised descriptors should result in consistent interpretations and decrease or eliminate ambiguity in reports resulting in a higher probability of accuracy in assigning the risk of malignancy and, subsequently, optimal patient management. The US lexicon is based upon supporting evidence for the performance of terms with regards to classification of the mass as benign or malignant and common usage of terms. A large part of the lexicon is based upon terms in use by the International Ovarian Tumor Analysis Group (IOTA). These terms demonstrate consistency regarding performance in the evaluation of malignancy risk and have been supplemented with other modifying, non-IOTA descriptors. Risk categories were developed using the most predictive descriptors in the lexicon that, in combination, include all possible lesions. The risk table is based on statistics collected by IOTA/ADNEX models. Cases that illustrate the O-RADS-US Lexicon and Risk Stratification System will be discussed.

09:32
C. ORADS: MRI
I. Thomassin-Naggara; Paris/FR
Learning Objectives

1. To understand a new lexicon for ovarian/adnexal mass evaluation on MRI.
2. To understand the use of the lexicon in the development of a risk stratification and management system.
3. To apply O-RADS-MRI to case management.

This website uses cookies. Learn more